Literature DB >> 8081385

The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.

M A Whitney1, P Jakobs, M Kaback, R E Moses, M Grompe.   

Abstract

Fanconi anemia (FA) is an autosomal recessive disease for which at least four complementation groups exist. Recently the gene that corrects the defect in Fanconi anemia complementation group C cells (FACC) has been cloned. We have previously identified a common mutation in the FACC gene, which accounts for a majority of FA cases in Ashkenazi Jewish individuals. We here describe the use of allele-specific oligonucleotide (ASO) hybridization to determine the frequency of this mutation among additional Jewish FA patients and to determine the carrier frequency in the Jewish population. The common IVS4 + 4A-->T allele was found on 19/23 (83%) Jewish FA chromosomes, indicating that it is indeed responsible for most cases of FA among Ashkenazi Jews. The carrier frequency was 2/314 for Jewish individuals and the mutant allele was not detected in 130 non-Jewish controls.

Entities:  

Mesh:

Year:  1994        PMID: 8081385     DOI: 10.1002/humu.1380030402

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.

Authors:  Iris Schrijver; Maigi Külm; Phyllis I Gardner; Eugene P Pergament; Morris B Fiddler
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

2.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.

Authors:  Philip S Rosenberg; Hannah Tamary; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Fanconi anemia gene editing by the CRISPR/Cas9 system.

Authors:  Mark J Osborn; Richard Gabriel; Beau R Webber; Anthony P DeFeo; Amber N McElroy; Jordan Jarjour; Colby G Starker; John E Wagner; J Keith Joung; Daniel F Voytas; Christof von Kalle; Manfred Schmidt; Bruce R Blazar; Jakub Tolar
Journal:  Hum Gene Ther       Date:  2015-02       Impact factor: 5.695

4.  Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.

Authors:  A J Tipping; T Pearson; N V Morgan; R A Gibson; L P Kuyt; C Havenga; E Gluckman; H Joenje; T de Ravel; S Jansen; C G Mathew
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 5.  Update of the human and mouse Fanconi anemia genes.

Authors:  Hongbin Dong; Daniel W Nebert; Elspeth A Bruford; David C Thompson; Hans Joenje; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2015-11-24       Impact factor: 4.639

6.  Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.

Authors:  Orna Steinberg-Shemer; Tracie A Goldberg; Joanne Yacobovich; Carina Levin; Ariel Koren; Shoshana Revel-Vilk; Tal Ben-Ami; Amir A Kuperman; Vered Shkalim Zemer; Amos Toren; Joseph Kapelushnik; Ayelet Ben-Barak; Hagit Miskin; Tanya Krasnov; Sharon Noy-Lotan; Orly Dgany; Hannah Tamary
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

7.  FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.

Authors:  Benilde García-de Teresa; Sara Frias; Bertha Molina; María Teresa Villarreal; Alfredo Rodriguez; Alessandra Carnevale; Gerardo López-Hernández; Lilia Vollbrechtshausen; Alberto Olaya-Vargas; Leda Torres
Journal:  Mol Genet Genomic Med       Date:  2019-05-01       Impact factor: 2.183

8.  Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.

Authors:  Rex H Lee; Hyunseok Kang; Sue S Yom; Agata Smogorzewska; Daniel E Johnson; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

9.  SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.

Authors:  Ka-Kui Chan; Zahi Abdul-Sater; Aditya Sheth; Dana K Mitchell; Richa Sharma; Donna M Edwards; Ying He; Grzegorz Nalepa; Steven D Rhodes; D Wade Clapp; Elizabeth A Sierra Potchanant
Journal:  Mol Oncol       Date:  2021-06-28       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.